TP53 and neoplasm: Our previous investigation revealed that P53 mutation occurs in almost 60% of Chinese patients with HBV-related HCC, suggesting that mutation of the P53 gene not only abolishes the P53 tumor-suppressor function but also endows the mutant P53 protein with a gain-of-function to promote tumorigenesis16.